Continuous ST Segment Monitoring and Incidence of Clinical Events in Implantable Cardioverter Defibrillator (ICD) Patients

A prospective, multicenter, anonymous registry to collect data in the population of patients implanted with a St Jude Medical (SJM) AnalyST/AnalyST Accel VR/DR device intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12610000041055

Acronym

AnalyST

Enrollment

1123

Registered

2010-01-14

Start date

2008-11-03

Completion date

2011-05-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to 1/ Identify the population of patients selected by physicians to be implanted with a SJM ICD featuring the ST segment monitoring feature. 2/ Document the incidence of ST segment shifts, symptomatic or not, in that population and their possible relationships with clinical events. 3/ Document the change in patient management related to availability of device diagnostics.

Interventions

The study is aimed at 1/ identifying the patient population selected by physicians to be implanted with a SJM ICD featuring the ST segment monitoring feature. 2/ Documenting the incidence of ST segment shifts and possible relationships with clinical events and 3/ the change in patient management related to the device diagnositic availabiltiy. Patients will be observed for a period of 12 months with a maximum of Four Follow up visits

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Any patient candidate implanted with a St Jude Medical AnalyST or AnalyST Accel DR/VR device, as per current guidelines can be enrolled in the study.

Exclusion criteria

Patient not willing or able to understand and sign the 'data transfer authorization'

Outcome results